CVS Group Valuation
| 4C9 Stock | EUR 14.00 0.20 1.41% |
At this time, the firm appears to be fairly valued. CVS Group plc shows a prevailing Real Value of €13.48 per share. The current price of the firm is €14.0. Our model approximates the value of CVS Group plc from analyzing the firm fundamentals such as profit margin of 0.05 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that CVS Group's price fluctuation is not too volatile at this time. Calculation of the real value of CVS Group plc is based on 3 months time horizon. Increasing CVS Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CVS stock is determined by what a typical buyer is willing to pay for full or partial control of CVS Group plc. Since CVS Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CVS Stock. However, CVS Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.0 | Real 13.48 | Hype 14.0 | Naive 14.1 |
The real value of CVS Stock, also known as its intrinsic value, is the underlying worth of CVS Group plc Company, which is reflected in its stock price. It is based on CVS Group's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CVS Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CVS Group plc helps investors to forecast how CVS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CVS Group more accurately as focusing exclusively on CVS Group's fundamentals will not take into account other important factors: CVS Group Total Value Analysis
CVS Group plc is presently estimated to have takeover price of 1.9 B with market capitalization of 1.52 B, debt of (84.3 M), and cash on hands of 19.83 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CVS Group fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.9 B | 1.52 B | (84.3 M) | 19.83 M |
CVS Group Investor Information
About 78.0% of the company shares are owned by institutions such as pension funds. The company last dividend was issued on the 17th of November 2022. Based on the analysis of CVS Group's profitability, liquidity, and operating efficiency, CVS Group plc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in October.CVS Group Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CVS Group has an asset utilization ratio of 106.95 percent. This implies that the Company is making €1.07 for each dollar of assets. An increasing asset utilization means that CVS Group plc is more efficient with each dollar of assets it utilizes for everyday operations.CVS Group Ownership Allocation
CVS Group holds a total of 71.39 Million outstanding shares. The majority of CVS Group plc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CVS Group plc to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in CVS Group. Please pay attention to any change in the institutional holdings of CVS Group plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CVS Group Profitability Analysis
The company reported the revenue of 554.2 M. Net Income was 25.7 M with profit before overhead, payroll, taxes, and interest of 239.1 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates CVS Group's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in CVS Group and how it compares across the competition.
About CVS Group Valuation
The stock valuation mechanism determines CVS Group's current worth on a weekly basis. Our valuation model uses a comparative analysis of CVS Group. We calculate exposure to CVS Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CVS Group's related companies.CVS Group plc engages in veterinary, online pharmacy, and retail businesses. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom. CVS GROUP operates under Personal Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6150 people.
8 Steps to conduct CVS Group's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CVS Group's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CVS Group's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CVS Group's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CVS Group's revenue streams: Identify CVS Group's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CVS Group's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CVS Group's growth potential: Evaluate CVS Group's management, business model, and growth potential.
- Determine CVS Group's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CVS Group's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CVS Stock analysis
When running CVS Group's price analysis, check to measure CVS Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Group is operating at the current time. Most of CVS Group's value examination focuses on studying past and present price action to predict the probability of CVS Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Group's price. Additionally, you may evaluate how the addition of CVS Group to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |